|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar
|
|
2
|
Servick K: Breast cancer: Breast cancer: A
world of differences. Science. 343:1452–1453. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Carey LA, Perou CM, Livasy CA, Dressler
LG, Cowan D, Conway K, Karaca G, Troester MA, Tse CK, Edmiston S,
et al: Race, breast cancer subtypes, and survival in the Carolina
Breast Cancer Study. JAMA. 295:2492–2502. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Higgins MJ and Baselga J: Targeted
therapies for breast cancer. J Clin Invest. 121:3797–3803. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Perou CM, Sørlie T, Eisen MB, van de Rijn
M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA,
et al: Molecular portraits of human breast tumours. Nature.
406:747–752. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sørlie T, Perou CM, Tibshirani R, Aas T,
Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey
SS, et al: Gene expression patterns of breast carcinomas
distinguish tumor subclasses with clinical implications. Proc Natl
Acad Sci USA. 98:10869–10874. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang Y and Zhou BP: Epithelial-mesenchymal
Transition - A Hallmark of Breast Cancer Metastasis. Cancer Hallm.
1:38–49. 2013. View Article : Google Scholar
|
|
8
|
Al Saleh S, Al Mulla F and Luqmani YA:
Estrogen receptor silencing induces epithelial to mesenchymal
transition in human breast cancer cells. PLoS One. 6:e206102011.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lamouille S, Xu J and Derynck R: Molecular
mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell
Biol. 15:178–196. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Al Saleh S, Sharaf LH and Luqmani YA:
Signalling pathways involved in endocrine resistance in breast
cancer and associations with epithelial to mesenchymal transition
(Review). Int J Oncol. 38:1197–1217. 2011.PubMed/NCBI
|
|
11
|
Luqmani YA, Al Azmi A, Al Bader M, Abraham
G and El Zawahri M: Modification of gene expression induced by
siRNA targeting of estrogen receptor alpha in MCF7 human breast
cancer cells. Int J Oncol. 34:231–242. 2009.
|
|
12
|
Khajah MA, Al Saleh S, Mathew PM and
Luqmani YA: Differential effect of growth factors on invasion and
proliferation of endocrine resistant breast cancer cells. PLoS One.
7:e418472012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Khajah MA, Almohri I, Mathew PM and
Luqmani YA: Extracellular alkaline pH leads to increased metastatic
potential of estrogen receptor silenced endocrine resistant breast
cancer cells. PLoS One. 8:e763272013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Khajah MA, Mathew PM, Alam-Eldin NS and
Luqmani YA: Bleb formation is induced by alkaline but not acidic pH
in estrogen receptor silenced breast cancer cells. Int J Oncol.
46:1685–1698. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Khajah MA and Luqmani YA: Involvement of
Membrane Blebbing in Immunological Disorders and Cancer. Medical
principles and practice: International journal of the Kuwait
University. Health Sci Cent. 25(Suppl 2): 18–27. 2016.
|
|
16
|
Shi Z, Zhang T, Luo L, Zhao H, Cheng J,
Xiang J and Zhao C: Aquaporins in human breast cancer:
Identification and involvement in carcinogenesis of breast cancer.
J Surg Oncol. 106:267–272. 2012. View Article : Google Scholar
|
|
17
|
Kasa P, Farran B, Prasad GLV and Nagaraju
GP: Aquaporins in female specific cancers. Gene. 700:60–64. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
López-Campos JL, Sánchez Silva R, Gómez
Izquierdo L, Márquez E, Ortega Ruiz F, Cejudo P, Barrot Cortés E,
Toledo Aral JJ and Echevarría M: Overexpression of Aquaporin-1 in
lung adenocarcinomas and pleural mesotheliomas. Histol Histopathol.
26:451–459. 2011.PubMed/NCBI
|
|
19
|
Yoshida T, Hojo S, Sekine S, Sawada S,
Okumura T, Nagata T, Shimada Y and Tsukada K: Expression of
aquaporin-1 is a poor prognostic factor for stage II and III colon
cancer. Mol Clin Oncol. 1:953–958. 2013. View Article : Google Scholar
|
|
20
|
El Hindy N, Bankfalvi A, Herring A,
Adamzik M, Lambertz N, Zhu Y, Siffert W, Sure U and Sandalcioglu
IE: Correlation of aquaporin-1 water channel protein expression
with tumor angiogenesis in human astrocytoma. Anticancer Res.
33:609–613. 2013.PubMed/NCBI
|
|
21
|
Guo X, Sun T, Yang M, Li Z, Li Z and Gao
Y: Prognostic value of combined aquaporin 3 and aquaporin 5
overexpression in hepatocellular carcinoma. BioMed Res Int.
2013:2065252013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Otterbach F, Callies R, Adamzik M, Kimmig
R, Siffert W, Schmid KW and Bankfalvi A: Aquaporin 1 (AQP1)
expression is a novel characteristic feature of a particularly
aggressive subgroup of basal-like breast carcinomas. Breast Cancer
Res Treat. 120:67–76. 2010. View Article : Google Scholar
|
|
23
|
Qin F, Zhang H, Shao Y, Liu X, Yang L,
Huang Y, Fu L, Gu F and Ma Y: Expression of aquaporin1, a water
channel protein, in cytoplasm is negatively correlated with
prognosis of breast cancer patients. Oncotarget. 7:8143–8154. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Esteva-Font C, Jin BJ and Verkman AS:
Aquaporin-1 gene deletion reduces breast tumor growth and lung
metastasis in tumor-producing MMTV-PyVT mice. FASEB J.
28:1446–1453. 2014. View Article : Google Scholar :
|
|
25
|
Kang S, Chae YS, Lee SJ, Kang BW, Kim JG,
Kim WW, Jung JH, Park HY, Jeong JH, Jeong JY, et al: Aquaporin 3
Expression Predicts Survival in Patients with HER2-positive Early
Breast Cancer. Anticancer Res. 35:2775–2782. 2015.PubMed/NCBI
|
|
26
|
Huang YT, Zhou J, Shi S, Xu HY, Qu F,
Zhang D, Chen YD, Yang J, Huang HF and Sheng JZ: Identification of
Estrogen Response Element in Aquaporin-3 Gene that Mediates
Estrogen-induced Cell Migration and Invasion in Estrogen
Receptor-positive Breast Cancer. Sci Rep. 5:124842015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cao C, Sun Y, Healey S, Bi Z, Hu G, Wan S,
Kouttab N, Chu W and Wan Y: EGFR-mediated expression of aquaporin-3
is involved in human skin fibroblast migration. Biochem J.
400:225–234. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cao XC, Zhang WR, Cao WF, Liu BW, Zhang F,
Zhao HM, Meng R, Zhang L, Niu RF, Hao XS, et al: Aquaporin3 is
required for FGF-2-induced migration of human breast cancers. PLoS
One. 8:e567352013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li YB, Sun SR and Han XH: Down-regulation
of AQP4 Inhibits Proliferation, Migration and Invasion of Human
Breast Cancer Cells. Folia Biol (Praha). 62:131–137. 2016.
|
|
30
|
Lee SJ, Chae YS, Kim JG, Kim WW, Jung JH,
Park HY, Jeong JY, Park JY, Jung HJ and Kwon TH: AQP5 expression
predicts survival in patients with early breast cancer. Ann Surg
Oncol. 21:375–383. 2014. View Article : Google Scholar
|
|
31
|
Jung HJ, Park JY, Jeon HS and Kwon TH:
Aquaporin-5: A marker protein for proliferation and migration of
human breast cancer cells. PLoS One. 6:e284922011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
33
|
Hara-Chikuma M and Verkman AS: Aquaporin-3
facilitates epidermal cell migration and proliferation during wound
healing. J Mol Med (Berl). 86:221–231. 2008. View Article : Google Scholar
|
|
34
|
Luo L, Yang R, Zhao S, Chen Y, Hong S,
Wang K, Wang T, Cheng J, Zhang T and Chen D: Decreased miR-320
expression is associated with breast cancer progression, cell
migration, and invasiveness via targeting Aquaporin 1. Acta Biochim
Biophys Sin (Shanghai). 50:473–480. 2018. View Article : Google Scholar
|
|
35
|
Zhu Z, Jiao L, Li T, Wang H, Wei W and
Qian H: Expression of AQP3 and AQP5 as a prognostic marker in
triple-negative breast cancer. Oncol Lett. 16:2661–2667.
2018.PubMed/NCBI
|
|
36
|
Khajah MA and Luqmani YA: Involvement of
Membrane Blebbing in Immunological Disorders and Cancer. Med Princ
Pract. 25(Suppl 2): 18–27. 2016. View Article : Google Scholar
|
|
37
|
Monzani E, Bazzotti R, Perego C and La
Porta CA: AQP1 is not only a water channel: It contributes to cell
migration through Lin7/beta-catenin. PLoS One. 4:e61672009.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Schwab A: Function and spatial
distribution of ion channels and transporters in cell migration. Am
J Physiol Renal Physiol. 280:F739–F747. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hu J and Verkman AS: Increased migration
and metastatic potential of tumor cells expressing aquaporin water
channels. FASEB J. 20:1892–1894. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Khajah MA, Mathew PM and Luqmani YA:
Na+/K+ ATPase activity promotes invasion of
endocrine resistant breast cancer cells. PLoS One. 13:e01937792018.
View Article : Google Scholar
|
|
41
|
Chen J, Wang T, Zhou YC, Gao F, Zhang ZH,
Xu H, Wang SL and Shen LZ: Aquaporin 3 promotes
epithelial-mesenchymal transition in gastric cancer. J Exp Clin
Cancer Res. 33:382014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Li A, Lu D, Zhang Y, Li J, Fang Y, Li F
and Sun J: Critical role of aquaporin-3 in epidermal growth
factor-induced migration of colorectal carcinoma cells and its
clinical significance. Oncol Rep. 29:535–540. 2013. View Article : Google Scholar
|
|
43
|
Liu S, Zhang S, Jiang H, Yang Y and Jiang
Y: Co-expression of AQP3 and AQP5 in esophageal squamous cell
carcinoma correlates with aggressive tumor progression and poor
prognosis. Med Oncol. 30:6362013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Arif M, Kitchen P, Conner MT, Hill EJ,
Nagel D, Bill RM, Dunmore SJ, Armesilla AL, Gross S, Carmichael AR,
et al: Downregulation of aquaporin 3 inhibits cellular
proliferation, migration and invasion in the MDA-MB-231 breast
cancer cell line. Oncol Lett. 16:713–720. 2018.PubMed/NCBI
|
